Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology. CVI: GABAAReceptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans
Werner Sieghart, Miroslav M. Savić
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 836-878
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Single-particle cryo-EM at atomic resolution
Takanori Nakane, Abhay Kotecha, Andrija Sente, et al.
Nature (2020) Vol. 587, Iss. 7832, pp. 152-156
Open Access | Times Cited: 743
Shared structural mechanisms of general anaesthetics and benzodiazepines
Jeong Joo Kim, Anant Gharpure, Jinfeng Teng, et al.
Nature (2020) Vol. 585, Iss. 7824, pp. 303-308
Open Access | Times Cited: 288
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Thomas D. Prévot, Etienne Sibille
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 151-167
Closed Access | Times Cited: 192
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels
S P H Alexander, Alistair Mathie, John A. Peters, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. S2
Open Access | Times Cited: 94
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 41
Resolving native GABAA receptor structures from the human brain
Jia Zhou, Colleen Noviello, Jinfeng Teng, et al.
Nature (2025)
Closed Access | Times Cited: 2
Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors
Tija C. Jacob
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 95
Direct Structural Insights into GABAA Receptor Pharmacology
Jeong Joo Kim, Ryan Hibbs
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 6, pp. 502-517
Open Access | Times Cited: 91
Shisa7 is a GABA A receptor auxiliary subunit controlling benzodiazepine actions
Wenyan Han, Jun Li, Kenneth A. Pelkey, et al.
Science (2019) Vol. 366, Iss. 6462, pp. 246-250
Open Access | Times Cited: 83
GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne, Arnold S. Lippa, Michael M. Poe, et al.
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108035-108035
Open Access | Times Cited: 71
Differential assembly diversifies GABAA receptor structures and signalling
Andrija Sente, Rooma Desai, Katerina Naydenova, et al.
Nature (2022) Vol. 604, Iss. 7904, pp. 190-194
Open Access | Times Cited: 64
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 39
Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective
Marcel P Goldschen-Ohm
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1784-1784
Open Access | Times Cited: 38
GABAA receptor subtypes and benzodiazepine use, misuse, and abuse
Elif Engin
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 29
Insights on benzodiazepines' potential in Alzheimer's disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Life Sciences (2023) Vol. 320, pp. 121532-121532
Closed Access | Times Cited: 23
Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in mice
Rebecca M. Jarvis, Josephine Ng, Anna Nathanson, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100957-100957
Open Access | Times Cited: 22
Sex- and age-related changes in GABA signaling components in the human cortex
Madhavi Pandya, Thulani H. Palpagama, Clinton Turner, et al.
Biology of Sex Differences (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 74
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
Bernhard Lüscher, Hanns Möhler
F1000Research (2019) Vol. 8, pp. 751-751
Open Access | Times Cited: 71
A structural perspective on GABAA receptor pharmacology
Suzanne Scott, A.R. Aricescu
Current Opinion in Structural Biology (2019) Vol. 54, pp. 189-197
Closed Access | Times Cited: 69
Endozepines and their receptors: Structure, functions and pathophysiological significance
Marie‐Christine Tonon, Hubert Vaudry, Julien Chuquet, et al.
Pharmacology & Therapeutics (2019) Vol. 208, pp. 107386-107386
Open Access | Times Cited: 63
Single-particle cryo-EM at atomic resolution
Takanori Nakane, Abhay Kotecha, Andrija Sente, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 57
Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update
Samuele Maramai, Mohamed Benchekroun, Simon E. Ward, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 7, pp. 3425-3446
Open Access | Times Cited: 55
Looking for Novelty in an “Old” Receptor: Recent Advances Toward Our Understanding of GABAARs and Their Implications in Receptor Pharmacology
David Castellano, Ryan D. Shepard, Wei Lü
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 46
Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance
Md. Mominur Rahman, Md. Rezaul Islam, Md. Yamin, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-27
Open Access | Times Cited: 35
Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 221-230
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top